Barely Significant
← all excerpts

Management of Metastatic Colorectal Cancer (mCRC): Real-World Recommendations.

South Asian J Cancer · 2024 · PMC11888815 · PMID 40060353

Europe PMCDOI
1
hedged sentence
0.0359
closest p · 0.7× alpha
0.0359
boldest claim

The sentences

did not reach statistical significanceP = 0.0359actually significant
No wonder OS difference did not reach statistical significance (hazard ratio, 0.74; 95% confidence interval, 0.53–1.03; p IS 0.0359 (P = 0.0359)). 17 Another alternative is the combination of nivolumab and ipilumab, 43 but it is usually not preferred over single-agent pembrolizumab.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.